Company: HCTI
Filing Date: 2025-11-28
Form Type: S-3
Source: 0001213900-25-115888
Chunk: 27

Company: Healthcare Triangle, Inc.
Filing Date: 2025-11-28
Form: S-3
Chunk 27
---
is subject to the approval of the Investors.

The Notes rank senior
to all future indebtedness of the Company and pari passu with all other Notes issued under the Purchase Agreement. Any unpaid amount bears
interest at the past due rate of 18% per annum. The Notes are convertible at any time after the issuance date at the election of the holder.
The conversion price is the greater of (i) eighty percent (80%) of the lowest Closing Price during the five trading days immediately preceding
the conversion date and (ii) $0.38 per share. Upon receipt of a conversion notice, the Company must deliver the applicable shares no later
than one trading day thereafter. Failure to timely deliver shares results in liquidated damages equal to two percent (2%) of the outstanding
principal amount per month until cured. The Notes include customary events of default and provide that upon an uncured Event of Default
the Mandatory Default Amount becomes immediately due and payable.

In connection with the
Purchase Agreement, on the Company entered into a Registration Rights Agreement (the “RRA”) with the Investors. The RRA requires
the Company to file a registration statement covering the resale of at least 300% of the maximum number of Conversion Shares issuable
at the Floor Price. The filing deadline is the tenth calendar day after signing, and the effectiveness deadline is 60 days after the Filing
Deadline. Failure to meet these deadlines or maintain an effective registration statement results in liquidated damages of 2% per month,
up to a maximum of 20%. The Company has also agreed to use commercially reasonable efforts to obtain stockholder approval for the issuance
of the shares of Common Stock issuable upon pursuant to the Notes in accordance with Nasdaq Listing Rules.

The Offering resulted
in gross proceeds to the Company of approximately $6,000,000, before deducting placement agent fees and commissions and other offering
expenses. RBW Capital Partners LLC (a division of Dawson James Securities, Inc.) acted as placement agent for the offering. As compensation
for such placement agent services, the Company has agreed to pay RBW, an aggregate cash fee equal to 8.0% of the gross proceeds received
by the Company, plus $100,000 for its legal fees and expenses.

<div align='center'>USE OF PROCEEDS</div>

The Selling Stockholders will receive all of the
proceeds of the sale of shares of Common Stock offered from time to time pursuant to this prospectus. Accordingly, we will not receive